Metabolomics of Escherichia coli Treated with the Antimicrobial Carbon Monoxide-Releasing Molecule CORM-3 Reveals Tricarboxylic Acid Cycle as Major Target
In the last decade, carbon monoxide-releasing molecules (CORMs) have been shown to act against several pathogens and to be promising antimicrobials. However, the understanding of the mode of action and reactivity of these compounds on bacterial cells is still deficient. In this work, we used a metab...
Autor principal: | |
---|---|
Outros Autores: | , , |
Formato: | article |
Idioma: | eng |
Publicado em: |
2020
|
Assuntos: | |
Texto completo: | http://hdl.handle.net/10362/91639 |
País: | Portugal |
Oai: | oai:run.unl.pt:10362/91639 |